Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking Wegovy with prednisone at the same time raises a real clinical question — one worth understanding before you start either medicine. Prednisone and other corticosteroids can raise blood glucose levels, and Wegovy (semaglutide) affects appetite, gastric emptying and metabolic function. The two are not automatically incompatible, but the interaction has implications that a prescriber needs to weigh up for you specifically. These are prescription-only medicines, and combining them is a clinical decision, not a self-management one.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
There's a misconception that floats around weight-loss forums: that steroids simply cancel out semaglutide, so there's no point taking both. That's not quite right, and it's worth letting that idea go gently.
The real picture is more specific. Prednisone (a corticosteroid used for inflammation, autoimmune conditions and a range of other diagnoses) raises blood glucose by reducing insulin sensitivity and increasing glucose production by the liver. Wegovy (semaglutide) works partly by stimulating insulin secretion in a glucose-dependent way and by slowing how quickly food leaves the stomach. These two effects pull in different directions on blood sugar, which matters most for people who are using Wegovy alongside a diabetes diagnosis.
For people without diabetes who are on a short course of prednisone, the blood glucose concern is less acute, though not absent. The more immediate consideration is that semaglutide's effect on gastric emptying can slow the absorption of oral medicines taken at the same time. Prednisone is an oral tablet, so there is a theoretical possibility that peak absorption is delayed. Whether this matters clinically depends on the dose, the indication and the individual. The full picture of semaglutide interactions is broader than corticosteroids alone, your prescriber will look at everything.
Tell both clinicians. That sounds obvious, but in practice it gets missed, especially when a short steroid course is prescribed by a GP who isn't the same prescriber managing your weight treatment, or when a hospital clinic adds a medicine without sight of your full medicines list.
The Wegovy patient information leaflet advises telling your prescriber about all medicines you take, including those prescribed recently. That includes corticosteroids. Your prescriber may want to monitor your blood glucose more closely during a steroid course, adjust other medicines if relevant, or simply note the combination and watch for symptoms.
If you're managing type 2 diabetes alongside obesity, the stakes are higher. Steroid-induced hyperglycaemia can be significant, and semaglutide's glucose-lowering effect may not fully offset it, particularly at higher prednisone doses or with prolonged courses. The NHS patient-level guidance on semaglutide sets out the broader interaction landscape, and the question of what to avoid with Wegovy includes several categories of medicine worth reviewing with your clinical team.
One practical note: if a steroid course is prescribed for a week or two, your Wegovy dose and schedule don't change unless your prescriber directs otherwise. Never adjust timing or dose yourself, that's the prescriber's call.
A few. People with a personal or family history of type 2 diabetes, those with prediabetes, or anyone already showing elevated fasting glucose should flag this combination explicitly. Steroid courses in these groups can push blood sugar into a range that warrants monitoring or, in some cases, temporary medical management in its own right.
Long-term corticosteroid use (for conditions like inflammatory bowel disease, lupus or severe asthma) adds another layer. If you're on maintenance-dose prednisone rather than a short burst, this isn't a transient interaction; it's an ongoing clinical context that your prescriber needs to factor into any treatment plan involving Wegovy.
Weight gain is also a recognised side effect of corticosteroid use, which creates an irony: you may be prescribed prednisone for a condition partly worsened by obesity, while the prednisone itself makes weight management harder. Semaglutide's appetite-suppressing effect may provide some counterbalance, but expecting it to neutralise significant steroid-related weight change isn't realistic. Your clinical review at the point of consent is the right moment to discuss your full medicines list, including any steroid therapy.
For anyone thinking about the cost of managing multiple conditions privately, our Wegovy price comparison page covers what transparent private pricing looks like and what it should include. The NHS guidance on semaglutide is a reliable source for understanding both the medicine's profile and what interactions to flag with your clinical team, the NHS medicines page for semaglutide is plain-English and kept current.
A thorough clinical assessment looks at your full medicines list, your current blood glucose readings if relevant, your BMI, your weight-related conditions and your reasons for steroid therapy. The prescriber isn't looking for a reason to refuse; they're looking to understand the whole picture so the treatment is genuinely safe for you.
At nume, every consultation is read by a GPhC-registered Independent Prescriber, not processed by an algorithm. If your medicines list includes prednisone or another corticosteroid, that's precisely the kind of detail the clinical review is designed to catch and work through. The FAQs cover more about how the process works if you want a sense of what to expect before you start. The MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk is also worth knowing about, it's how patients and clinicians report unexpected interactions or side effects for medicines like semaglutide.
If you'd like to discuss your specific circumstances, speak to our prescribers through a free consultation and they'll review everything properly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.